nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A network meta-analysis of direct oral anticoagulants for portal vein thrombosis in cirrhosis
|
Ng, Cheng Han |
|
|
15 |
5 |
p. 1196-1206 |
artikel |
2 |
APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy
|
Lau, George |
|
|
15 |
5 |
p. 1031-1048 |
artikel |
3 |
Clinical course of liver injury induced by immune checkpoint inhibitors in patients with advanced malignancies
|
Ito, Takanori |
|
|
15 |
5 |
p. 1278-1287 |
artikel |
4 |
Connection between HPS and ACLF: a solution of chaos?
|
Maruyama, Hitoshi |
|
|
15 |
5 |
p. 1049-1052 |
artikel |
5 |
Diabetes is associated with poor short-term prognosis in patients with hepatitis B virus-related acute-on-chronic liver failure
|
Hu, Han |
|
|
15 |
5 |
p. 1093-1102 |
artikel |
6 |
Effect of microbiota metabolites on the progression of chronic hepatitis B virus infection
|
Sun, Xiu |
|
|
15 |
5 |
p. 1053-1067 |
artikel |
7 |
Efficacy and safety of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in preventing HBV vertical transmission of high maternal viral load
|
Li, Baijun |
|
|
15 |
5 |
p. 1103-1108 |
artikel |
8 |
Efficacy of apatinib in patients with sorafenib–transarterial chemoembolization refractory hepatocellular carcinoma: a retrospective study
|
Cao, Yanyan |
|
|
15 |
5 |
p. 1268-1277 |
artikel |
9 |
First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients
|
Huang, Jee-Fu |
|
|
15 |
5 |
p. 1136-1147 |
artikel |
10 |
Hepatic stellate cells-specific LOXL1 deficiency abrogates hepatic inflammation, fibrosis, and corrects lipid metabolic abnormalities in non-obese NASH mice
|
Yang, Aiting |
|
|
15 |
5 |
p. 1122-1135 |
artikel |
11 |
Hepatopulmonary syndrome is related to the development of acute-on-chronic liver failure and poor prognosis in cirrhotic patients
|
Han, Seul Ki |
|
|
15 |
5 |
p. 1207-1214 |
artikel |
12 |
Histological severity of nonalcoholic fatty liver disease is associated with 10-year risk for atherosclerotic cardiovascular disease
|
Park, Ji Hye |
|
|
15 |
5 |
p. 1148-1159 |
artikel |
13 |
Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B
|
Lee, Hye Won |
|
|
15 |
5 |
p. 1083-1092 |
artikel |
14 |
Increased risk of cancer in patients with primary sclerosing cholangitis
|
Lundberg Båve, Aiva |
|
|
15 |
5 |
p. 1174-1182 |
artikel |
15 |
Iodized oil computed tomography versus ultrasound-guided radiofrequency ablation for early hepatocellular carcinoma
|
Wu, Chih-Horng |
|
|
15 |
5 |
p. 1247-1257 |
artikel |
16 |
Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
|
Yeh, Ming-Lun |
|
|
15 |
5 |
p. 1109-1121 |
artikel |
17 |
Portal vein thrombosis associated with high 14-day and 6-week rebleeding in patients after oesophageal variceal band ligation: a retrospective, multicentre, nested case–control study
|
Gao, Zhanjuan |
|
|
15 |
5 |
p. 1183-1195 |
artikel |
18 |
Survival analysis between laparoscopic and open hepatectomy for hepatocellular carcinoma: a meta-analysis based on reconstructed time-to-event data
|
Sun, Qiang |
|
|
15 |
5 |
p. 1215-1235 |
artikel |
19 |
Targeted inhibition of FGF19/FGFR cascade improves antitumor immunity and response rate in hepatocellular carcinoma
|
Tai, David Wai Meng |
|
|
15 |
5 |
p. 1236-1246 |
artikel |
20 |
The differential activation of cardiovascular hormones across distinct stages of portal hypertension predicts clinical outcomes
|
Hartl, Lukas |
|
|
15 |
5 |
p. 1160-1173 |
artikel |
21 |
The global trends and regional differences in incidence and mortality of hepatitis A from 1990 to 2019 and implications for its prevention
|
Cao, Guiying |
|
|
15 |
5 |
p. 1068-1082 |
artikel |
22 |
Volumetric assessment and clinical predictors of cirrhosis in patients undergoing hepatectomy for hepatocellular carcinoma with presumed normal liver function
|
Shimizu, Takayuki |
|
|
15 |
5 |
p. 1258-1267 |
artikel |